As of 2025-06-13, the Intrinsic Value of Vaxcyte Inc (PCVX) is -19.77 USD. This PCVX valuation is based on the model Peter Lynch Fair Value. With the current market price of 34.46 USD, the upside of Vaxcyte Inc is -157.36%.
Based on its market price of 34.46 USD and our intrinsic valuation, Vaxcyte Inc (PCVX) is overvalued by 157.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -19.77 - -19.77 | -19.77 | -157.36% |
| P/E | (58.20) - (79.07) | (62.07) | -280.1% |
| DDM - Stable | (24.14) - (66.62) | (45.38) | -231.7% |
| DDM - Multi | (6.57) - (14.59) | (9.11) | -126.4% |
| Market Cap (mil) | 4,445.34 |
| Beta | 1.72 |
| Outstanding shares (mil) | 129.00 |
| Enterprise Value (mil) | 4,445.34 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.40% |
| Cost of Debt | 5.00% |
| WACC | 8.04% |